注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Anavex Life Sciences Corp是一家臨床階段的生物製藥公司。該公司致力於開髮用於治療神經退行性疾病和神經發育疾病的差異化療法。其先導化合物ANAVEX2-73正在開髮用於治療阿爾茨海默病、帕金森病和其他中樞神經系統疾病,包括罕見疾病,如雷特綜合徵是一種由X-連鎖基因、甲基-CpG結合蛋白2(MECP2)引起的罕見的嚴重神經單基因疾病。其候選產品還包括ANAVEX 3-71、ANAVEX 1-41、ANAVEX 1066和ANAVEX 1037。ANAVEX 3-71是一種治療認知障礙的中樞神經系統(CNS)可穿透的潛在疾病改善療法。ANAVEX 1-41是一種sigma-1激動劑。ANAVEX 1066是一種混合sigma-1/sigma-2配體,設計用於治療潛在治療神經性和內臟疼痛。ANAVEX 1037專為治療前列腺癌和胰腺癌而設計。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Timo Grimmer | - | 2022 | Member of Scientific Advisory Board |
Marwan Noel Sabbagh | 57 | 2023 | Member of Scientific Advisory Board |
John Harrison | - | 2013 | Member of the Scientific Advisory Board |
Claus van der Velden | 50 | 2018 | Lead Independent Director |
Peter Donhauser | 57 | 2017 | Independent Director |
Jiong Ma | 59 | 2021 | Independent Chairman |
Jeffrey L. Cummings | 74 | 2011 | Member of the Scientific Advisory Board |
Tangui Nicolas Maurice | - | - | Member of the Scientific Advisory Board |
Norman Relkin | - | 2014 | Member of the Scientific Advisory Board |
Athanasios Skarpelos | 56 | 2013 | Independent Director |
Andrew J. Cole | - | 2017 | Member of Scientific Advisory Board |
Christopher U. Missling | 57 | 2013 | President, CEO, Secretary & Director |
Steffen Thomas | 58 | 2015 | Independent Director |
Daniel Weintraub | - | 2016 | Member of the Scientific Advisory Board |
Ottavio Arancio | - | 2013 | Member of the Scientific Advisory Board |
Corinne Lasmézas | - | 2015 | Member of the Scientific Advisory Board |
Paul S. Aisen | - | 2011 | Member of the Scientific Advisory Board |
Jacqueline A. French | - | 2015 | Member of the Scientific Advisory Board |
Dag Aarsland | - | 2018 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核